BeOne Medicines (ONC) Earnings Date, Estimates & Call Transcripts $337.82 +3.42 (+1.02%) As of 04:00 PM Eastern Add Compare Share Share Earnings Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFDA EventsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestTrendsBuy This Stock BeOne Medicines Earnings Summary BeOne Medicines issued Q2 2025 earnings on August 6, 2025, reporting an EPS of $0.84, which beat the consensus estimate of $0.48 by $0.36. Quarterly revenue was reported to be $1.32 billion, above analysts' expectations of $1.24 billion. With a trailing EPS of -$1.73, BeOne Medicines' earnings are expected to grow next year, from ($5.82) to $0.71 per share. Q2 2025 Earnings ResourcesQ2 2025 Earnings ReportLatest Q2 2025 Earnings DateAug. 6ConfirmedConsensus EPS (Aug. 6) $0.48 Actual EPS (Aug. 6) $0.84 Beat By $0.36 Actual Revenue (Aug. 6) $1.32B Get BeOne Medicines Earnings Alerts Want to stay updated on the latest earnings announcements and upcoming reports? Sign up for Earnings360's daily newsletter to receive timely earnings updates on BeOne Medicines and other key companies, straight to your inbox. Sign Up View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. Skip Charts & View Estimated and Actual Earnings DataONC Earnings Estimates and Actuals by QuarterEarnings Estimates and Acutals by Quarter Chart DescriptionThe chart below shows up to four years of a company's earnings history. The dark blue line represents the company's actual earnings per share. The light blue area represents the range of Wall Street analysts' earnings estimates for each quarter.ONC Estimated and Actual Revenue by QuarterEstimated Revenue and Actual Revenue by Quarter Chart DescriptionThe chart below shows up to four years of a company's revenue history. The dark blue line represents the company's actual revenue. The light blue line represents the company's estimated revenue based on the consensus of Wall Street analysts for each quarter. BeOne Medicines Analyst EPS EstimatesQuarterNumber of EstimatesLow EstimateHigh EstimateAverage EstimateRevenue EstimateCompany Revenue GuidanceQ1 20251-$0.61-$0.61-$0.61Q2 20251-$0.08-$0.08-$0.08Q3 20251-$0.05-$0.05-$0.05Q4 20251-$0.04-$0.04-$0.04 BeOne Medicines Earnings History by Quarter Custom Range 3 Months 6 Months Year-to-Date 1 Year 2 Years 3 Years 5 Years 10 Years Time Frame Start Date End Date Export to Excel DateQuarterConsensus EstimateReported EPSBeat/MissGAAP EPSRevenue EstimateActual RevenueDetails8/6/2025Q2 2025$0.48$0.84+$0.36$0.84$1.24B$1.32B5/7/2025Q1 2025-$0.71$1.22+$1.93$0.01$1.12B$1.12B2/27/2025Q4 2024-$0.88-$1.43 -$0.55-$1.43$1.09B$1.13B BeOne Medicines Earnings - Frequently Asked Questions When did BeOne Medicines announce their last quarterly earnings? BeOne Medicines (NASDAQ:ONC) last announced its quarterly earning data on Wednesday, August 6, 2025. Learn more on ONC's earnings history. What guidance has BeOne Medicines issued on next quarter's earnings? BeOne Medicines updated its FY 2025 earnings guidance on Thursday, August, 7th. The company issued revenue guidance of $5.0 billion-$5.3 billion. Did BeOne Medicines beat their earnings estimates last quarter? In the previous quarter, BeOne Medicines (NASDAQ:ONC) reported $0.84 earnings per share (EPS) to beat the analysts' consensus estimate of $0.48 by $0.36. Learn more on analysts' earnings estimate vs. ONC's actual earnings. How much revenue does BeOne Medicines generate each year? BeOne Medicines (NASDAQ:ONC) has a recorded annual revenue of $4.56 billion. How much profit does BeOne Medicines generate each year? BeOne Medicines (NASDAQ:ONC) has a recorded net income of -$644.79 million. ONC has generated -$1.73 earnings per share over the last four quarters. What is BeOne Medicines' EPS forecast for next year? BeOne Medicines' earnings are expected to grow from ($5.82) per share to $0.71 per share in the next year. More Earnings Resources from MarketBeat Related Companies SNY Earnings GSK Earnings TAK Earnings ARGX Earnings INSM Earnings BNTX Earnings TEVA Earnings GMAB Earnings SMMT Earnings RDY Earnings Earnings Tools Today's Earnings Tomorrow's Earnings Next Week's Earnings Upcoming Earnings Calls Earnings Newsletter Earnings Call Transcripts Earnings Beats & Misses Corporate Guidance Earnings Screener Earnings By Country U.S. Earnings Reports Canadian Earnings Reports U.K. Earnings Reports Latest Articles Berkshire-Backed Lennar Slides After Weak Q3 EarningsWall Street Eyes +30% Upside in Synopsys After Huge Earnings FallRH Stock Slides After Mixed Earnings and Tariff ConcernsCelsius Stock Surges After Blowout Earnings and Pepsi DealWhy DocuSign Could Be a SaaS Value Play After Q2 EarningsWhy Broadcom's Q3 Earnings Were a Huge Win for AVGO BullsAffirm Crushes Earnings Expectations, Turns Bears into Believers This page (NASDAQ:ONC) was last updated on 9/22/2025 by MarketBeat.com Staff From Our PartnersHe Called Nvidia at $1.10. Now, He Says THIS Stock Will…The original Magnificent Seven returned 16,894%—turning $7K into $1.18 million. Now, the man who called Nvi...The Oxford Club | SponsoredPrepare for the “Mar-a-Lago Accord” Money ShockWhy Are Wall Street Insiders Moving Their Money to This ONE Asset? Something far more consequential for you...Stansberry Research | Sponsored$3,600 gold is nice ... but here’s what most gold bugs are missingGold just surged past $3,600, but Weiss Ratings expert Sean Brodrick says the real upside is in select gold st...Weiss Ratings | SponsoredForget AI Stocks — This Device Will REPLACE the MicrochipWhile everyone's chasing the same AI plays, George Gilder is focused on something completely different. He ...Banyan Hill Publishing | Sponsored1 Hour Once A DayMy top income trading expert, Dave Aquino, just released a 1-hour trading strategy designed specifically to he...Base Camp Trading | SponsoredThe next AI Hype Spike is days away — don’t miss itOn this date, AI could trigger the kind of predictable surge that's already paid out 61%… 158%… and even 382% ...Brownstone Research | SponsoredTrump Devises the Death of the IRS ☠️Trump has just signed an executive order creating America's first-ever National Investment Fund — a game-chang...Angel Publishing | SponsoredINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding BeOne Medicines Ltd. - Sponsored ADR Please log in to your account or sign up in order to add this asset to your watchlist. Share BeOne Medicines With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free ONC Stock Alerts